{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-004785","form_type":"8-K","ticker":"PRME","cik":"0001894562","company_name":"Prime Medicine, Inc.","filed_at":"2024-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.260487+00:00","generated_at":"2026-06-06T02:42:11.772415+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Prime Medicine reports preliminary cash of ~$135.2M as of Dec 31, 2023","bullets":["Preliminary unaudited cash, equivalents, short-term investments, and restricted cash total ~$135.2M.","Excluding $13.5M restricted cash, liquid assets are ~$121.7M.","Company has not yet completed year-end close; final results may differ materially.","Estimates are management-prepared and not audited; no assurance of final figures."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-004785","json":"https://secwatch.observer/filing/0001628280-24-004785.json","markdown":"https://secwatch.observer/filing/0001628280-24-004785.md","text":"https://secwatch.observer/filing/0001628280-24-004785.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894562/000162828024004785/0001628280-24-004785-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894562/000162828024004785/prme-20240214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T02:42:11.772415+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}